What to know
- Presentation Day/Time: Friday, April 25, 2:55–4:00 pm
- Presenter: Ria Ghai, PhD, EIS officer assigned to the National Center for Emerging and Zoonotic Infectious Diseases, Division of Foodborne, Waterborne, and Environmental Diseases

What did we do?
- On January 21, 2025, CDC launched a multistate investigation with Georgia Department of Public Health, Texas Department of State Health Services, and Washington State Department of Health after a physician notified CDC of 12 family members in three states who were experiencing symptoms associated with histoplasmosis after touring Venado Caves in Costa Rica.
What did we find?
- Six adults and six children toured Venado Caves on December 24, 2024. They reported bat sightings and direct bat guano contact.
- All 12 developed symptoms consistent with histoplasmosis 8 to 19 days after exposure.
- A family member who was vacationing with the other 12 but did not attend the cave tour, did not develop symptoms. No other recreational activities raised suspicion of Histoplasma exposure.
- Five adults and 1 child sought medical care. Among these, three initially received antibiotics, which are ineffective for treating histoplasmosis, and two received corticosteroids, which can worsen fungal infections.
- One adult was hospitalized and received antifungal medication.
- Fungal testing was performed on five adults. Two were positive for Histoplasma by blood antigen test; one was also antibody-positive.
- All 12 persons had recovered or were improving by late January 2025.
Why does it matter?
- This is the second reported outbreak of histoplasmosis linked to Venado Caves, suggesting ongoing risk of Histoplasma exposure.
- Tourists who develop symptoms after visiting Venado Caves are encouraged to seek health care and disclose travel history.
- Clinicians should obtain travel history and consider histoplasmosis in patients with compatible illness that have entered caves with bats.
***This presentation has updated data that will be shared at the EIS Conference.
Abstract Category: Fungal Diseases